ATI Pharmacology 2026/2027 – Advanced
Practice Questions with Detailed Rationales
Question 1
A client with paroxysmal supraventricular tachycardia (SVT) refractory to vagal
maneuvers is prescribed adenosine. Which physiological action and administration
technique are essential for therapeutic efficacy?
A. Administer via slow IV infusion over 15 minutes to prevent sudden reflex
bradycardia.
B. Deliver as an ultra-rapid IV bolus over 1 to 2 seconds immediately followed by a
rapid 20 mL normal saline flush.
C. Inject intramuscularly into the vastus lateralis to establish sustained active plasma
concentrations.
D. Dilute in 100 mL of 5% dextrose in water and infuse over 1 hour.
Correct Answer: B
Rationale: Adenosine has an extremely short elimination half-life of under 10
seconds due to rapid erythrocyte and endothelial uptake. It must be administered as
an ultra-rapid intravenous push over 1 to 2 seconds through a central or proximal
peripheral line, immediately followed by a rapid saline flush.
Question 2
A client in acute decompensated heart failure is receiving intravenous milrinone.
Which pharmacological mechanism and physiological outcome should the nurse
,monitor?
A. Beta-1 receptor stimulation causing peripheral arterial vasoconstriction and
increased afterload
B. Phosphodiesterase-3 (PDE3) inhibition increasing cyclic AMP, resulting in
positive inotropy and systemic vasodilation
C. Direct inhibition of the cardiac Na+/K+ ATPase pump producing chronotropic
acceleration
D. Antagonism of vascular endothelin receptors leading to selective renal
vasoconstriction
Correct Answer: B
Rationale: Milrinone is a phosphodiesterase-3 inhibitor that slows cyclic AMP
degradation in myocardial and vascular smooth muscle cells. Elevated intracellular
cAMP increases myocardial contractile force (positive inotropy) while inducing
systemic arterial and venous vasodilation (inodilation), significantly reducing cardiac
preload, afterload, and pulmonary capillary wedge pressure.
Question 3
A client experiencing a severe hypertensive crisis is receiving an intravenous infusion
of sodium nitroprusside at 5 mcg/kg/min for 72 hours. Which clinical manifestation
indicates potential thiocyanate or cyanide toxicity?
A. Acute hyperactive deep tendon reflexes and severe respiratory alkalosis
B. Metabolic acidosis, progressive mental confusion, lethargy, and cherry-red venous
blood
,C. Severe sinus bradycardia accompanied by acute localized facial flushing
D. Profuse watery diarrhea, hypokalemia, and elevated serum amylase
Correct Answer: B
Rationale: Nitroprusside metabolism generates free cyanide, which the liver
converts to thiocyanate for renal elimination. Prolonged infusions exceeding 48 to 72
hours or high infusion rates can saturate hepatic rhodanase, causing lethal cyanide
poisoning, severe metabolic lactic acidosis, altered mental status, and impaired tissue
cellular oxygen utilization.
Question 4
A client with chronic heart failure is prescribed sacubitril/valsartan. What is the
pharmacological rationale for combining a neprilysin inhibitor with an angiotensin
receptor blocker?
A. Neprilysin inhibition increases protective natriuretic peptides, while the ARB
blocks compensatory angiotensin II activation.
B. Neprilysin inhibition accelerates bradykinin degradation to prevent life-
threatening angioedema.
C. The combination selectively destroys cardiac beta-1 receptors to eliminate
tachycardia.
D. Valsartan prevents neprilysin from degrading circulating systemic aldosterone.
Correct Answer: A
Rationale: Sacubitril inhibits neprilysin, the endopeptidase responsible for degrading
endogenous natriuretic peptides (ANP, BNP, bradykinin), promoting vasodilation and
natriuresis. Because neprilysin also degrades angiotensin II, combining sacubitril
, with valsartan blocks the vasoconstrictive and aldosterone-secreting actions of
unopposed angiotensin II, significantly reducing heart failure mortality.
Question 5
A client taking amiodarone for refractory ventricular tachycardia is prescribed oral
sotalol. Which baseline electrocardiographic parameter is critical to evaluate prior to
administering sotalol?
A. PR interval duration
B. QTc interval duration
C. Delta wave amplitude
D. QRS electrical axis
Correct Answer: B
Rationale: Sotalol exhibits Class III antiarrhythmic properties that prolong cardiac
action potential duration and ventricular repolarization, causing QT-interval
prolongation. Administering sotalol with or following other QT-prolonging agents
(amiodarone) creates an additive risk of precipitating lethal polymorphic ventricular
tachycardia, known as torsades de pointes.
Question 6
A nurse is preparing to administer eplerenone to a client with post-myocardial
infarction heart failure. Which concurrent laboratory finding represents a strict
contraindication?
A. Serum sodium level of 136 mEq/L
Practice Questions with Detailed Rationales
Question 1
A client with paroxysmal supraventricular tachycardia (SVT) refractory to vagal
maneuvers is prescribed adenosine. Which physiological action and administration
technique are essential for therapeutic efficacy?
A. Administer via slow IV infusion over 15 minutes to prevent sudden reflex
bradycardia.
B. Deliver as an ultra-rapid IV bolus over 1 to 2 seconds immediately followed by a
rapid 20 mL normal saline flush.
C. Inject intramuscularly into the vastus lateralis to establish sustained active plasma
concentrations.
D. Dilute in 100 mL of 5% dextrose in water and infuse over 1 hour.
Correct Answer: B
Rationale: Adenosine has an extremely short elimination half-life of under 10
seconds due to rapid erythrocyte and endothelial uptake. It must be administered as
an ultra-rapid intravenous push over 1 to 2 seconds through a central or proximal
peripheral line, immediately followed by a rapid saline flush.
Question 2
A client in acute decompensated heart failure is receiving intravenous milrinone.
Which pharmacological mechanism and physiological outcome should the nurse
,monitor?
A. Beta-1 receptor stimulation causing peripheral arterial vasoconstriction and
increased afterload
B. Phosphodiesterase-3 (PDE3) inhibition increasing cyclic AMP, resulting in
positive inotropy and systemic vasodilation
C. Direct inhibition of the cardiac Na+/K+ ATPase pump producing chronotropic
acceleration
D. Antagonism of vascular endothelin receptors leading to selective renal
vasoconstriction
Correct Answer: B
Rationale: Milrinone is a phosphodiesterase-3 inhibitor that slows cyclic AMP
degradation in myocardial and vascular smooth muscle cells. Elevated intracellular
cAMP increases myocardial contractile force (positive inotropy) while inducing
systemic arterial and venous vasodilation (inodilation), significantly reducing cardiac
preload, afterload, and pulmonary capillary wedge pressure.
Question 3
A client experiencing a severe hypertensive crisis is receiving an intravenous infusion
of sodium nitroprusside at 5 mcg/kg/min for 72 hours. Which clinical manifestation
indicates potential thiocyanate or cyanide toxicity?
A. Acute hyperactive deep tendon reflexes and severe respiratory alkalosis
B. Metabolic acidosis, progressive mental confusion, lethargy, and cherry-red venous
blood
,C. Severe sinus bradycardia accompanied by acute localized facial flushing
D. Profuse watery diarrhea, hypokalemia, and elevated serum amylase
Correct Answer: B
Rationale: Nitroprusside metabolism generates free cyanide, which the liver
converts to thiocyanate for renal elimination. Prolonged infusions exceeding 48 to 72
hours or high infusion rates can saturate hepatic rhodanase, causing lethal cyanide
poisoning, severe metabolic lactic acidosis, altered mental status, and impaired tissue
cellular oxygen utilization.
Question 4
A client with chronic heart failure is prescribed sacubitril/valsartan. What is the
pharmacological rationale for combining a neprilysin inhibitor with an angiotensin
receptor blocker?
A. Neprilysin inhibition increases protective natriuretic peptides, while the ARB
blocks compensatory angiotensin II activation.
B. Neprilysin inhibition accelerates bradykinin degradation to prevent life-
threatening angioedema.
C. The combination selectively destroys cardiac beta-1 receptors to eliminate
tachycardia.
D. Valsartan prevents neprilysin from degrading circulating systemic aldosterone.
Correct Answer: A
Rationale: Sacubitril inhibits neprilysin, the endopeptidase responsible for degrading
endogenous natriuretic peptides (ANP, BNP, bradykinin), promoting vasodilation and
natriuresis. Because neprilysin also degrades angiotensin II, combining sacubitril
, with valsartan blocks the vasoconstrictive and aldosterone-secreting actions of
unopposed angiotensin II, significantly reducing heart failure mortality.
Question 5
A client taking amiodarone for refractory ventricular tachycardia is prescribed oral
sotalol. Which baseline electrocardiographic parameter is critical to evaluate prior to
administering sotalol?
A. PR interval duration
B. QTc interval duration
C. Delta wave amplitude
D. QRS electrical axis
Correct Answer: B
Rationale: Sotalol exhibits Class III antiarrhythmic properties that prolong cardiac
action potential duration and ventricular repolarization, causing QT-interval
prolongation. Administering sotalol with or following other QT-prolonging agents
(amiodarone) creates an additive risk of precipitating lethal polymorphic ventricular
tachycardia, known as torsades de pointes.
Question 6
A nurse is preparing to administer eplerenone to a client with post-myocardial
infarction heart failure. Which concurrent laboratory finding represents a strict
contraindication?
A. Serum sodium level of 136 mEq/L
